Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 17;11(4):591.
doi: 10.3390/biom11040591.

The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis

Hanna Sternby  1 , Hannes Hartman  1 , Henrik Thorlacius  1 , Sara Regnér  1
Affiliations

The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis

Hanna Sternby et al. Biomolecules. .

Abstract

Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0-24 and 25-48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-values) of IL-1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α were calculated. Differences between severity groups, predictive capacity of the biomarkers and association with severe disease were analyzed. Paired comparison of samples (n = 115) taken at 0-24 and 25-48 h after onsets of AP showed a change over time for IL-1β, IL-6, IL-8 and IL-10 (p < 0.05) and a significant difference between severity groups after 24 h. In ROC-analysis an IL-6 cut-off level of 196.6 pg/mL could differentiate severe AP (sensitivity 81.9, specificity 91.3). The delta-values of IL-1β and IL-6 were significantly associated with severe outcomes (odds ratios 1.085 and 1.002, respectively). Data of this work demonstrate a distinct change in IL-1β, IL-8, IL-10 and IL-6 over the first 48 h after onset of AP. The temporal development of biomarkers can assist in the early stratification of the disease. Herein IL-1β and IL-6 were associated with severe disease, however the prognostic capacity of investigated biomarkers is low.

Keywords: acute pancreatitis; biomarkers; chronology; interleukins; prognostic markers; severity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Peery A.F., Crockett S.D., Murphy C.C., Lund J.L., Dellon E.S., Williams J.L., Jensen E.T., Shaheen N.J., Barritt A.S., Lieber S.R., et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156:254–272. doi: 10.1053/j.gastro.2018.08.063. - DOI - PMC - PubMed
    1. Yadav D., Lowenfels A.B. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1252–1261. doi: 10.1053/j.gastro.2013.01.068. - DOI - PMC - PubMed
    1. De-Madaria E., Sánchez-Martin C., Carrillo I., Vege S.S., Chooklin S., Bilyak A., Mejuto R., Mauritz V., Hegyi P., Márta K., et al. Design and validation of a patient-reported outcome measure scale in acute pancreatitis: The PAN-PROMISE study. Gut. 2021;70:139–147. doi: 10.1136/gutjnl-2020-320729. - DOI - PubMed
    1. Demcsák A., Soós A., Kincses L., Capunge I., Minkov G., Kovacheva-Slavova M., Nakov R., Wu D., Huang W., Xia Q., et al. Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis–An international cohort study. Pancreatology. 2020;20:1323–1331. doi: 10.1016/j.pan.2020.08.009. - DOI - PubMed
    1. Meher S., Mishra T.S., Sasmal P.K., Rath S., Sharma R., Rout B., Sahu M.K. Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis. J. Biomark. 2015;1:519534. doi: 10.1155/2015/519534. - DOI - PMC - PubMed

Publication types

LinkOut - more resources